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Assessing available information on the burden 
of sepsis: global estimates of incidence, 
prevalence and mortality
Objective Sepsis is a complex and hard-to-define condition with 
many different interactions with other disorders. Presently, there are 
no estimates of the burden of sepsis and septicaemia at the global 
level and it was not included in the initial Global Burden of Disease 
study. Non-maternal sepsis has only recently received attention as a 
substantial global public health problem. The aim of this study was 
to assess available data on the burden of non-maternal sepsis, severe 
sepsis and septic shock in the community and to identify key gaps 
in information needed to estimate the global burden of sepsis.
Methods Literature review of English language-based studies report-
ing on the incidence, prevalence, mortality or case-fatality of sepsis, 
severe sepsis and septic shock. The available literature was searched 
using the MEDLINE database of citations and abstracts of biomedi-
cal research articles published between 1980 and 2008.
Findings 8 studies reported incidence of sepsis, severe sepsis or sep-
tic shock at the national level (4 from the USA and 1 from Brazil, the 
UK, Norway and Australia). No studies on the incidence, prevalence, 
mortality or case-fatality from sepsis in developing countries were 
found.  The  population  sepsis  incidence  ranged  from  22  to 
240/100 000  (most  plausible  estimates  ranged  from  149  to 
240/100 000); of severe sepsis from 13 to 300/100 000 (most of the 
estimates were between 56 and 91/100 000); and of septic shock 
11/100 000. Case-fatality rate depends on the setting and severity of 
disease. It can reach up to 30% for sepsis, 50% for severe sepsis and 
80% for septic shock. While the data were compiled using strict in-
clusion and exclusion criteria, a degree of uncertainty still exists re-
garding the reported estimates.
Conclusion The few national-level reports available allow only a 
very crude estimation of the incidence of sepsis in developed coun-
tries while there is apparent lack of data from developing countries. 
A clear and universal definition of sepsis as well as the development 
of a sound epidemiological framework to begin addressing the mag-
nitude of this problem is urgently needed through research in devel-
oping countries.V
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Valid and comparable data on the population burden of 
diseases constitute an essential resource for guiding health 
policy and informing the process of resource allocation. 
This is particularly relevant in the developing world, where 
many diseases demand attention but resources are limited 
and budgets are tight.
The original Global Burden of Disease (GBD) study was 
commissioned in 1991 and conducted by the WHO in col-
laboration with Harvard University and others with the 
World Bank’s funding. Its purpose was to assess the burden 
of 107 different diseases and injuries as well as ten risk fac-
tors for diseases in 1990 [1]. The uniqueness of the study 
was reflected in its use of a multitude of sources for pro-
ducing the estimates and its specially designed new unit - 
Disability Adjusted Life Year (DALY) – for measuring the 
actual burden of disease. Soon following its launch, it be-
came clear that information the prevalence and incidence 
of most diseases and injuries was limited, especially in de-
veloping countries [2]. The new GBD study (commenced 
in the spring of 2007) is the first major effort since the orig-
inal GBD study was completed to carry out a complete sys-
tematic assessment of the data on all diseases and injuries 
and produce comprehensive and comparable estimates of 
the burden of diseases, injuries and risk factors for two time 
periods, 1990 and 2005.
Sepsis is a complex condition with many different interac-
tions with other disorders, and because of this it can be a 
difficult condition to define. Several medical terms are as-
sociated with sepsis, which further complicates diagnosis 
and identification of the condition. Sepsis is widely defined 
as a systemic inflammatory response. It has three states, 
which develop with increased severity: sepsis is followed 
by severe sepsis, and finally with septic shock (see Figure 
1 for a diagram of the natural history of the sepsis syn-
drome and Table 1 for different clinical and epidemiolog-
ical case definitions of the sepsis syndrome). Presently there 
are no estimates of the burden of sepsis at the global level 
and it was not included in the first GBD study. Specifically, 
while estimates for maternal sepsis are available [5], non-
maternal sepsis has only recently been receiving attention 
as a substantial global problem in terms of morbidity and 
mortality [3,6]. Sepsis is clearly a problem that has to date 
been neglected and underestimated by the global health 
community. It is primarily for this reason that sepsis has 
been included in the new GBD study.
Risk factors 
Infection1 
Sequelae in 
survivors 
Death 
Sepsis3 
cases 
Severe 
sepsis4 
cases 
Septic 
shock5 
cases 
Systemic 
inflammatory 
response2 
=  +  + 
Organ 
dysfunction 
Acute circulatory 
failure  =  +  = 
Susceptible 
non-diseased 
population 
1 
2 
3 
4  5 
6 
7 
8 
Outcomes for which data will be collected  
in a systematic review of the global burden  
of sepsis 
Shows intermediary processes (SIRS) or 
clinical features of the sepsis syndrome 
Progression to severe 
sepsis 
Progression to septic shock 
Figure 1 Natural history of sepsis diagram. Key to the diagram: 1) Potentially modifiable risk factors that increase the probability of 
infection, SIRS and sepsis in a non-diseased population or severe sepsis and septic shock in septic patients; 2) Incidence of sepsis: the 
rate at which susceptible or exposed individuals become newly affected by sepsis; 3) Remission: the rate at which individuals with 
sepsis stop being a sepsis case; 4) Sepsis-complication: the rate at which patients experience a complication of sepsis or start to suffer 
from sequelae of sepsis; 5) Case-fatality (or population mortality rate or relative risk of dying): the rate at which patients die from 
sepsis; 6) Complication-fatality: the rate at which patients die as a result of a complication of sepsis; 7) Individuals with sequelae who 
are exposed to the risk factor(s) and are susceptible to acquire infection, SIRS, sepsis, severe sepsis or septic shock again; 8) General 
mortality: the rate at which the population dies from any condition other than sepsis. Infection has been defined as a pathological 
process caused by invasion of normally sterile tissue/fluid/body cavity by pathogenic microorganisms; Systemic inflammatory 
response (SIRS) is a systemic inflammatory state characterized by changes in body temperature, heart rate, respiratory rate and 
leukocyte blood count; Sepsis is defined as confirmed or suspected infection and SIRS; Severe sepsis is defined as sepsis complicated 
by organ dysfunction; Septic shock in adults is defined as state of acute circulatory failure characterized by persistent arterial 
hypotension unexplained by other causes. Paediatric septic shock is defined as tachycardia with signs of decreased perfusion 
including decreased peripheral pulses, altered alertness, and cool extremities or reduced urinary output. Hypotension occurs later 
than in adults and is a sign of late and decompensated shock in children [3,4].V
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Producing estimates for the global burden of sepsis as part 
of the wider GBD study is a complex multi-stage process. 
The aim of the present study is to determine and evaluate 
the available information on the burden of sepsis in the 
community and to identify key gaps in information needed 
to estimate the global burden of sepsis. This research con-
stitutes a preliminary step in understanding the availabil-
ity of data on the burden of sepsis and will contribute, 
alongside other research, to the discussion surrounding 
whether or not it is possible to assess the global burden of 
sepsis. The specific objectives of the study are: (i) to under-
take a systematic review of the available English language-
based literature on the incidence, prevalence and mortality 
of sepsis, severe sepsis and septic shock; (ii) to apply clear 
inclusion and exclusion criteria to the data and tabulate the 
extracted results; (iii) to comment on the quality and 
spread of data found; and (iv) to discuss the potential fu-
ture use of this review’s findings and how the results can 
be further developed.
METHODS
Figure 2 outlines the research plan that was followed. The 
literature review was performed by undertaking free text 
searches in the title and abstract fields of the Medline data-
base for all human studies from 01/01/1980 to 28/02/2008. 
The following broad search terms were used: ‘sepsis’, 
‘septicaemia’/’septicaemia’, ‘incidence’, ‘prevalence’, ‘mor-
bidity’, mortality’, ‘etiology’/‘etiology’ and ‘risk factors’. Both 
the American and English spellings were used to ensure 
Table 1 Clinical and epidemiological case definitions of the sepsis syndrome [3,4]
OutcOme DefinitiOn clinical criteria* epiDemiOlOgical criteria relevant icD-9/10 cODes
Infection
Invasion of 
normally sterile 
tissue/fluid/ body 
cavity by 
microorganisms
Microbiologically confirmed or 
strongly suspected
Mortality data: Relevant ICD codes reported 
as underlying cause of death (primary code) 
on a death certificate / Hospital episode data: 
Relevant ICD codes reported as main 
condition on hospital episode records
ICD-9: 001-009, 020-027, 
031, 034, 038-041, 
098-099, 110-118, 130-136 
/ ICD-10: A00-A09, 
A20-A28, A31-A32, A39, 
A42-A49, A54-A64, 
A65-A69, A70-A74, 
A75-A79, A90-A99, 
B35-B49, B50-B64, 
B95-B97, B99, J00-J39, 
L00-L08, N39.0
Non-infective 
causes
Causes of SIRS that 
are not attributed 
to infectious agents
Clinically confirmed trauma, 
thermal injury, or sterile 
inflammatory processes
Mortality data: Relevant ICD codes reported 
as underlying cause of death (primary code) 
on a death certificate / Hospital episode data: 
Relevant ICD codes reported as main 
condition on hospital episode records
ICD-9: 574.0, 577.0, 
800-904, 910-959, 996-999 
/ ICD-10: J95, K81.0, K85, 
S00-S99, T00-T14, 
T20-T32, T33-T35
Systemic 
inflammatory 
response 
(SIRS)
Systemic activation 
of the innate 
immune response, 
regardless of cause
Two or more of the following: 
temperature >38°C or <36°C; 
heart rate >90 b/min; respiratory 
rate >20 b/min or Paco2<32 mm 
Hg; WBC count >12 000/ mm3 or 
<4000/mm3 or >10% band forms
Mortality data: Relevant ICD codes reported 
as any (primary or other) cause of death on a 
death certificate / Hospital episode data: 
Relevant ICD codes reported as main or 
other condition on hospital episode records
ICD-9: 995.90, 995.93
Sepsis
Clinical syndrome 
defined by the 
presence of both 
infection and SIRS
Microbiologically confirmed or 
strongly suspected infection and 
two or more of the above (see 
SIRS clinical criteria; this 
definition does not reflect the 
heterogeneity of causes of SIRS/
sepsis syndrome, including 
diverse non-infective causes)
Mortality data: Relevant ICD codes reported 
as any (primary or other) cause of death on a 
death certificate / Hospital episode data: 
Relevant ICD codes reported as main or 
other condition on hospital episode records
ICD-9: 003.1, 020.2, 038, 
630-638, 995.91 / ICD-10: 
A02.1, A09, A22.7, A24.1, 
A40-A41, A54.8, B37.7, 
J95.0, T80.2, T81.4, T82.6, 
T82.7, T83.5, T83.6, 
T84.5-T84.7, T85.7, T88.0
Severe sepsis
Sepsis complicated 
by organ 
dysfunction
Sepsis and organ dysfunction, 
hypoperfusion or hypotension; 
hypoperfusion may include:  
lactic acidosis or oliguria or  
acute alteration in mental status
Mortality data: Relevant ICD codes reported 
as any (primary or other) cause of death on a 
death certificate / Hospital episode data: 
Relevant ICD codes reported as main or 
other condition on hospital episode records
ICD-9: 276.2, 286.2, 286.6, 
286.9, 287.3-287.5, 293, 
348.1, 384.3, 357.82, 
359.81, 458.0, 458.8, 458.9, 
518.81, 518.82, 518.85, 
570, 572.2, 572.3, 580, 
584.5-584.9, 585, 780.01, 
780.09, 785.5, 785.51, 
785.59, 786.09, 796.3, 
799.1, 995.92, 995.94 / 
ICD-10: D65, E87.2, G93.4, 
I.95, I95.1, J96.0, K72, N17, 
R57.0, T80.2
Septic shock
Circulatory failure 
characterized by 
arterial hypoten-
sion unexplained 
by other causes
Sepsis induced hypotension 
(systolic blood pressure <90 mm 
Hg or a reduction of ≥40 mm Hg 
from baseline) despite adequate 
fluid resuscitation
Mortality data: Relevant ICD codes reported 
as any (primary or other) cause of death on a 
death certificate / Hospital episode data:
Relevant ICD codes reported as main or 
other condition on hospital episode records
ICD-9: 009.0, 415.12, 449, 
639.5, 785.51, 785.52, 
998.0 / ICD-10: A41.9, 
R57.0, T80.2V
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searches were thorough. The terms sepsis and septicaemia 
are used interchangeably in the academic literature [7], so 
both were included in the search and by truncating the 
word sepsis the search also included studies reviewing sep-
tic shock and severe sepsis.
The search also included the terms etiology and risk factors 
(see above) and while these have no relevance to this study 
they were included with the wider GBD study in mind. 
This study provides an opportunity to review this addi-
tional data for use in future research on the topic of sepsis. 
Going through these search results also gives a richer un-
derstanding of the subject matter and the pool of informa-
tion available about sepsis. To ensure the focus on the cho-
sen outcomes, the search term specified that an estimate 
for incidence, prevalence, mortality or morbidity was in-
cluded. The initial 13 848 results had their titles reviewed 
to narrow the number of studies down to those most use-
ful to achieve the aims. The initial screening retained all 
studies that were relevant to incidence, prevalence, case-
fatality, mortality or morbidity, and those that reported any 
numerical rates in their abstracts as well as any studies that 
were relevant to the GBD exercise. This resulted in 182 ab-
stracts. This initial filter was very broad to ensure that no 
potentially useful results were missed and the maximum 
number of studies possible could enter the next stage of 
the review.
In the second round of screening, the 182 retained entries 
were reviewed for reporting a specific figure for incidence, 
prevalence, mortality or morbidity, which was obtained 
from their original data, OR whether they were commu-
nity based studies. At this stage only articles that had their 
own original data were included. This was done to ensure 
that methodology behind the estimates reported could be 
assessed and that the quality of the study could be re-
viewed. All community studies were included as these are 
the most helpful type of studies for later projections of the 
burden to the larger population. At this point the 77 stud-
ies that were relevant to the GBD study were separated from 
the remaining results so as to ensure they were not includ-
ed in the final filter. For the remaining accepted 100 refer-
ences, full articles were obtained and reviewed to see if they 
fulfilled the inclusion criteria or were subject to exclusion 
criteria (explained in Figure 2).
At the final stage there were 12 articles remaining for ab-
straction from the first reviewer and 16 from the second 
reviewer, with 8 of them overlapping and further 10 re-
tained after deliberation process (Figure 2). The criteria 
during selection and deliberation were intended to be in-
Number of 
papers retrieved 
from searching  
the MEDLINE 
database: 
 
13848 
Numbers of 
papers retrieved 
from searching 
the MEDLINE 
database: 
  
13194 
 
Reviewer 1 
Reviewer 2 
Number of 
studies retained 
after applying 
filter 1: 
 
 
108 
 
Number of 
studies retained 
after applying 
filter 3: 
 
 
26 
 
Number of 
studies retained 
after applying 
filter 2: 
 
 
57 
 
Number of 
studies retained 
after applying 
filter 3: 
 
 
25 
Number of 
studies retained 
after applying 
filter 2: 
 
 
100 
Number of 
studies retained 
after applying 
filter 1: 
 
 
182 
FILTER 1 
#Incidence/ 
prevalence/ 
mortality/ 
case-fatality studies 
#Positive blood test 
results 
#Numerical 
epidemiological data 
Number of studies 
included in results: 
12 
Number of studies 
included in results: 
16 (possibly  
other 10) 
Of the studies 
included in results: 
Studies common to 
both reviewers: 8 
Unique studies: 10 
FILTER 2 
#Incidence/ 
prevalence/ 
mortality/ 
case-fatality studies 
#Community-based 
studies 
#Only studies of 
children or adults 
FILTER 3 
#Incidence/ 
prevalence/ 
mortality/ 
case-fatality studies 
#Set definition of sepsis 
#Observational period 
≥ 1 year 
#Random sample 
Screen titles  Screen 
abstracts 
Read full 
articles 
 
Screen titles  Read full 
articles 
Screen 
abstracts 
Figure 2 Results from the literature review of the global burden (incidence, prevalence and mortality/case-fatality) of sepsis.V
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clusive but also ensure only good quality studies were in-
cluded. The requirement for estimates to be from within 
the date range of 1980 – 2008 was enforced to ensure that 
the numbers reported were still relevant. The studies had 
to span at least 12 months to ensure that seasonal varia-
tions did not affect the results. The requirement for an ac-
ceptable definition of sepsis in the articles was important 
to ensure that all the studies complied with the ACCP or 
ICD code definitions of sepsis that were highlighted at the 
start of this investigation.
Studies that looked at specific population or sepsis as a sec-
ondary condition were not included as these cannot be gen-
eralized to the whole population. Neonatal and maternal 
sepsis studies were not included because these are regarded 
as separate conditions in the ICD classification system.
RESULTS
The few national-level reports available presented a very 
broad range of estimates for the incidence of sepsis in dif-
ferent countries. The three available estimates of the inci-
dence of sepsis in the USA, all of which were based on hos-
pital records, ranged from 500 000 [8] to 660 000 cases per 
year [9]. This roughly translates into an incidence of 300 
per 100 000 [10], and represents the most reliable estimate 
representative of the industrialized countries.
Some of the directly reported estimates of the incidence of 
sepsis from the smaller regions of Europe include 2007 es-
timate of 61 per 100 000 person-years in Valencia, Spain 
[11]; then about 123 per 100 000 per year incidence for hos-
pital admissions due to sepsis in 2006 in France [4], some 
38 cases per 100 000 in the adult population in Norway [12] 
and 149 cases per 100 000 in Finland in 1999 [13].
Much fewer studies are available for the developing world, 
and the etiological spectrum in low and middle-income 
countries is likely to be very different from the industrial-
ized ones. Therefore, the burden of sepsis in those parts of 
the world appears to remain uncharacterized. Table 2 pres-
ent the characteristics of identified studies of the incidence, 
prevalence and mortality rate of sepsis at the population 
level. All the studies reported their own original results 
based on hospital findings with a clearly defined credible 
population denominator which in some cases has been 
used to produce the national estimates that the studies re-
ported [9,10,13-25].
The search revealed only 8 studies that reported incidence 
of sepsis, severe sepsis or septic shock at the national level 
(4 from the USA and 1 each from Brazil, the UK, Norway 
and Australia) (Table 2). Over the period 1980-2008, there 
appeared to be no studies that assessed incidence, preva-
lence, mortality or morbidity from sepsis in low-income 
countries. Reported incidence of sepsis at the population 
level ranged from 22 to 240/100 000 (although the most 
plausible estimates were between 149 and 240/100 000); 
of severe sepsis from 13 to 300/100 000 (although most of 
the estimates were between 56 and 91/100 000); and of 
septic shock 11/100 000. Mortality rates depend on the set-
ting and severity of disease. It can reach up to 30% for sep-
sis, 50% for severe sepsis and 80% for septic shock.
Although the available information is still far from sufficient 
to understand thoroughly the magnitude of the global bur-
den of sepsis, studies convincingly show that sepsis is a 
significant health problem even in developed countries. We 
can deduce that more than 1 in 1000 people in developed 
countries develop sepsis each year, and between a third and 
a half of them progress to severe sepsis. Because sepsis is 
most frequently affecting those most vulnerable (infants, 
young children and very old and ailing patients), the mor-
tality rate is quite high, even at hospitals: it is about 10% 
for children, but much higher in the elderly, where it rang-
es between 15% and 80%, depending on the severity of 
sepsis and the rate of progression toward septic shock.
Those are the only general conclusions that one can reli-
ably draw from the available literature. The few national-
level reports available allow only a very crude estimation 
of the incidence of sepsis in developed countries. However, 
there is no information on developing countries. Specific 
definitions of the problem of sepsis and a sound epidemio-
logical framework to begin addressing the magnitude of 
this problem are urgently needed through research in de-
veloping countries.
DISCUSSION
The purpose of the GBD study is to quantify measures of 
what the burden of disease is on a national and interna-
tional scale in a form that is comprehensive and beneficial 
for the public health community. The present study can be 
considered as a preliminary step in an attempt to quantify 
the disease burden of sepsis, by assessing the availability of 
data and highlighting any gaps in existing data.
The definition of sepsis, severe sepsis and 
septic shock in available studies
A thorough inspection of studies highlights an almost com-
pletely consistent definition of sepsis that was concordant 
with that of the American College of Chest Physicians 
(ACCP)’s definition (1992) and the ICD codes (version 9) 
[26]. The ACCP’s definition appears to be the most highly 
regarded and in several studies the inclusion criteria was 
simply that they complied with the aforementioned defini-
tion [26]. Several studies also referred to the ICD codes as 
their means of identifying sepsis patients [26]. However, V
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variations in the studies’ definitions of sepsis were only 
seen in the Latin American studies highlighted by the Jai-
mes’ (2005) review [27]. The articles deemed all cases 
where there had been confirmation of bacteremia to be 
equivalent to a positive diagnosis of septicaemia. This does 
not comply with the ICD codes or the ACCP’s criteria. In 
all the studies cases were only included when positive 
blood cultures had confirmed the presence of bacteria. It 
was also clearly highlighted whether the study was looking 
at sepsis, septic shock or severe sepsis and no study com-
bined the three states.
Study populations and outcomes in 
available epidemiological studies of the 
burden of sepsis
Only a limited number of studies examined sepsis or its 
subsequent states in isolation. Much of the research fo-
cused on the epidemiology of sepsis in specific high-risk 
populations. The majority of available studies assessed 
post-operative sepsis incidence and burn related sepsis 
both of which are irrelevant to the aims of this study. The 
other major target of sepsis research was maternal and neo-
natal sepsis, an area that has received more attention than 
Table 2 Identified studies of the incidence, prevalence and mortality from sepsis
article cOuntry 
stuDieD geOgraphic setting pOpulatiOn stuDieD time setting anD 
DuratiOn
inciDence as repOrteD (prevalence 
Only where inDicateD)
mOrtality as 
repOrteD
Martin et 
al. [9]
United 
States Nationwide
750 million hospitalizations in 
the United States, identified 
10319 418 cases of sepsis
22-year period 240.4 per 100 000 
population
17.9% 
(1995-2000)
Silva et 
al. [14] Brazil
Five mixed ICUs in two 
different regions of Brazil: 
Sa ˘o Paulo State and Santa 
Catarina State
The total number of enrolled 
patients was 1383 (81.9%) 
out of 1688 patients admitted 
to the ICUs of the participat-
ing centers.
21 May 2001 
– 31 January 
2002
Sepsis: 61.4 per 1000 
patient-days / Severe sepsis: 
35.6 per 1000 patient-days 
/ Septic shock: 30.0 per 
1000 patient-days
Sepsis: 33.9% / 
Severe sepsis: 
46.9% / Septic 
shock: 52.2%
Elhag et 
al. [15] Kuwait
Jabriya, Kuwait City – 
Mubarak AI-Kabeer 
Teaching Hospital
3845 patients / 19 606 
patients
18 months 
(January 1982 
– June 1983)
10.9/1000 hospital 
admissions
Flaatten 
et al. [13] Norway Nationwide
All patients admitted to all 
Norwegian hospitals during 
1999
One year
National: 1.49 cases/1000 
inhabitants / Under 1: 
1.1/1000 / Over 80: 
8.7/1000
13.5%
Hoa et al. 
[16] Vietnam Ho Chi Minh City – south-
ern Viet Nam.
All patients admitted to the 
hospital whose blood culture 
was positive
1 June 1993 – 
30 May 1994
20.4 episodes per 1000 
admissions 6.0%
Harrison 
et al. [17]
United 
Kingdom Nationwide 34 3860 admissions to 172 
adult units
December 
1995 – January 
2005
Severe sepsis: 66 hospital 
admissions per 100 000 
population
Angus et 
al. [10] USA
Florida, Maryland, 
Massachusetts, New Jersey, 
New York, Virginia and 
Washington.
All acute care hospitalizations 
with ICD-9-CM codes for 
both a bacterial or fungal 
infectious process
1995 (12 
months)
3.0 cases per 1000 
population
Severe sepsis: 
28.6%
Braun et 
al. [18] USA
Midwest, Northeast, 
Southeast, and Western 
United States
Enrollees in 16 IPA network 
plans
1 July  1995 
– 31 December 
1999
Severe sepsis: 0.91 cases of 
per 1000 enrollees
Finfer et 
al. [19]
Australia 
and New 
Zealand
Twenty-three closed 
multi-disciplinary ICUs of 
21 hospitals (16 tertiary 
and 5 University affiliated) 
in Australia and New 
Zealand
Results are presented for 3543 
ICU admissions in 3338 
patients
1999 – 2000 0.77 per 1000 population
Engel et 
al. [20] Germany
Random sample of German 
hospitals in all 16 federal 
states of Germany and 
belonging to 310 hospitals
1380 hospitals (total number 
of beds: 488 727)
Sepsis prevalence: 12.4% / 
Severe sepsis prevalence: 
11.0%
Salvo et 
al. [21] Italy 99 Italian ICUs, distributed 
throughout the country
1101 patients who fit criteria 
from all the ICUs
April 1993 
– March 1994
Sepsis: 36.0% / 
Severe sepsis: 
52.0% / Septic 
shock: 81.8%
Watson 
et al. [22] USA
Florida, Maryland, 
Massachusetts, New Jersey, 
New York, Virginia and 
Washington
942 non-federal hospital 
admissions under 19 y olds.
1995 (12 
months)
Severe sepsis: 0.56 cases per 
1000 children / Severe 
sepsis, infants (<1 y): 5.16 
per 1000 / Severe sepsis, 
1–4 y: 0.49 per 1000 / 
Severe sepsis, 5–9 y: 0.22 
per 1000 / Severe sepsis, 
10-14 y: 0.20 per 1000 / 
Severe sepsis, 15–19 y: 0.37 
per 1000
ICU – intensive care unit, y – yearV
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non-maternal and non-neonatal sepsis and that was in-
cluded in the previous GBD Study.
The small number of community-based studies was disap-
pointing; consequently all the studies identified and in-
cluded were hospital-based. Their use raises questions 
about how representative the data are. For example, it is 
possible that such data are less likely to be representative 
because the rural, and usually poorer, population will be 
less likely to access these hospitals because of financial or 
transportation difficulties which results in their exclusion 
from the hospital population cohort [28]. As well as this 
limited representation it may also mean that the population 
denominators the studies state that have been used to cal-
culate their estimates are also inaccurate as a hospital may 
overestimate how many patients have access to its services. 
Hospital-based studies only report results from admitted 
patients and consequently excludes non-admitted sepsis 
cases. Any amount of misdiagnosis of sepsis patients may 
affect the reported estimates to an uncertain degree.
Few studies exist on sepsis incidence, prevalence and mor-
tality although several report on the etiology of sepsis; these 
results show detailed breakdowns of the proportion of sep-
tic infections caused by particular bacteria. The compara-
tive abundance of such studies might be explained by their 
usefulness in developing specific drug vaccines, antibiotics 
and treatment programmes. In addition, many studies 
briefly describe the various sequelae associated with sepsis. 
Figure 1 highlights the key aspects of the natural history 
of sepsis.
Integrity of the results for available 
epidemiological studies of sepsis
The few included studies inevitably reduce the integrity of 
the overall results as it becomes more challenging to deter-
mine the burden of sepsis from limited data. All efforts were 
made to try and obtain all the articles that were considered 
acceptable. Despite this, no incidence or mortality results 
reported from Africa and only one African study discussed 
the etiology of sepsis in Nigeria. Similarly, there were no 
studies from the Asian sub-continent or the rest of Asia, 
and the geographically closest incidence rates reported for 
the whole region were from Kuwait. The lack of results 
means that no clear conclusions could be drawn about sep-
sis across the world and only figures from isolated countries 
could be reported.
The few child sepsis studies probably highlight the fact that 
studies of neonatal sepsis were not included in this review. 
More reported estimates might be expected for children 
than adults because historically public health monitoring 
has been dominated by child health. With increasing child 
survival in developing countries and more adult deaths 
then the incidence of sepsis might also become a more size-
able problem. However, such a change in the burden of 
sepsis is expected to result in an exposure of the inadequa-
cy of data reported for adults.
Study limitations
The current literature review was limited to studies identi-
fied in the Medline databases but could have been extended 
other databases, including Embase, Web of Science, Global 
Health Search and the French search engine LILACS, United 
Nations and WHO databases, non-journal based data as well 
as any ‘gray literature’ in the form of white papers, un-pub-
lished research, government reports and working papers. 
Also, the inclusion of non-English language articles might 
have increased the completeness of the review. Several non-
English papers were excluded and others were not consid-
ered due to a lack of an English abstract. In addition, search 
limitations might also have been reduced and allowed a free 
text search rather than a title and abstract search. This was 
not feasible in the present context, however, because of the 
sheer number of results generated.
Burden of sepsis estimates and the GBD 
study
The estimates highlighted in this study can have a valuable 
impact by themselves as well as a significant impact through 
the GBD study. In addition to the sepsis incidence and mor-
tality estimates identified, additional research on preva-
lence and the sepsis severity could be used to then compute 
them into DALYs, which can help paint a picture of the 
gross impact of sepsis and not simply just the mortality, 
prevalence or the incidence in isolation. This is important 
as it means that sepsis will not just be viewed in terms of 
how many it kills but it will also include the impact that it 
has on patients that survive. As can be seen from the natu-
ral history diagram (Figure 1) there are many sequelae as-
sociated with sepsis that can have a life-long disabling im-
pact. Having this knowledge incorporated into the DALYs 
will help with getting a fuller picture of the impact of sep-
sis in the community. Such prioritisation may manifest in 
several ways; it can result in a more significant presence in 
both regional and global policy and strategy. However, once 
sepsis is recognized as an important contributor to burden 
of mortality and ill health, funding agencies may be more 
likely to consider funding interventions and treatment pro-
grammes (eg, vaccine and drug development) as well as 
investing more in research and development associated 
with sepsis.
Recommendations and suggested further 
research
The next step is to apply the literature review strategy to 
other databases to ensure that the main sources of relevant 
data have been considered. This may also mean the inclu-V
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sion of foreign language articles and having particularly rel-
evant studies translated to ensure that inclusion and exclu-
sion criteria can be applied fully. In order to truly understand 
the burden of sepsis more time needs to be invested in re-
viewing non-journal format data including national surveil-
lance data and other ‘gray’ literature available. Specifically, 
in light of the low results, alternative strategies should be 
tried as these might yield greater results. One alternative 
search strategy that needs considering focuses on the spe-
cific type of pathogens associated with sepsis. By conduct-
ing multiple literature reviews each focusing on a specific 
pathogen such as meningococcal or typhoid sepsis and 
gathering estimates for the incidence, prevalence and mor-
tality of each of these forms of sepsis it may be possible then 
to combine them all for an overall estimate of sepsis.
CONCLUSION
Understanding the scale by which sepsis impacts the com-
munity is important. The present results show that on av-
erage sepsis is reported to have an incidence of 56-91 cas-
es per 100 000 people, with a reported mortality rate of 
30%. These estimates are accompanied by wide uncertain-
ty bounds. This indicates that sepsis is a public health prob-
lem that the global health community needs to embrace 
more fully.
The limited results reported in this study highlight the need 
for greater investment in sepsis research and improved sur-
veillance and reporting of sepsis cases which may also re-
quire the development of comprehensive national and in-
ternational frameworks for data collection and reporting.
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